Cumberland Pharmaceuticals (CPIX) Profit After Tax Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -303.53% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.27% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 34.32% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.56 Mn | 112.69 Mn | - | -42.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -42.63% |
| Mar 31, 2026 | -361.69% |
| Dec 31, 2025 | 24.87% |
| Sep 30, 2025 | -26.81% |
| Jun 30, 2025 | 31.77% |
| Mar 31, 2025 | 166.08% |
| Dec 31, 2024 | 69.82% |
| Sep 30, 2024 | -46.48% |
| Jun 30, 2024 | -224.47% |
| Mar 31, 2024 | -1,204.25% |
| Dec 31, 2023 | -158.20% |
| Sep 30, 2023 | -147.93% |
| Jun 30, 2023 | 163.91% |
| Mar 31, 2023 | 112.28% |
| Dec 31, 2022 | 36.57% |
| Sep 30, 2022 | 59.89% |
| Jun 30, 2022 | -288.31% |
| Mar 31, 2022 | -299.84% |
| Dec 31, 2021 | -335.37% |
| Sep 30, 2021 | -119.06% |